Cargando…

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Establishing the optimal treatment for COVID-19 patients remains challenging. Specifically, immunocompromised and pre-diseased patients are at high risk for severe disease course and face limited therapeutic options. Convalescent plasma (CP) has been considered as therapeutic approach, but reliable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freise, Noemi F., Gliga, Smaranda, Fischer, Johannes, Lübke, Nadine, Lutterbeck, Matthias, Schöler, Miriam, Bölke, Edwin, Orth, Hans Martin, Feldt, Torsten, Roemmele, Christoph, Wilke, Dominik, Schneider, Jochen, Wille, Kai, Hohmann, Christian, Strauss, Richard, Hower, Martin, Ruf, Andreas, Schubert, Joerg, Isberner, Nora, Stecher, Melanie, Pilgram, Lisa, Vehreschild, Jörg J., Hanses, Frank, Luedde, Tom, Jensen, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643921/ https://www.ncbi.nlm.nih.gov/pubmed/36351986 http://dx.doi.org/10.1038/s41598-022-23200-1

Ejemplares similares

COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
por: Brozat, Jonathan Frederik, et al.
Publicado: (2022)

Hospitalized patients dying with SARS-CoV-2 infection—An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry
por: Raichle, Claudia, et al.
Publicado: (2022)

Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
por: Pilgram, Lisa, et al.
Publicado: (2023)

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
por: Brozat, Jonathan F., et al.
Publicado: (2022)

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
por: Rüthrich, Maria Madeleine, et al.
Publicado: (2020)

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
por: Schons, Maximilian J., et al.
Publicado: (2021)

Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
por: Schons, Maximilian J., et al.
Publicado: (2021)

First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
por: Jakob, Carolin E. M., et al.
Publicado: (2020)

Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS) and COKA registries
por: Zellmer, Stephan, et al.
Publicado: (2021)

Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018
por: Gliga, Smaranda, et al.
Publicado: (2021)

Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study
por: Meintrup, David, et al.
Publicado: (2021)

Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry
por: Stefan, Norbert, et al.
Publicado: (2022)

Prevalence of H. pylori among asymptomatic HIV-positive and negative individuals in Central Ethiopia and efficacy of eradication therapy
por: Mesfun, Million Getachew, et al.
Publicado: (2022)

Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
por: Huber, Meret K., et al.
Publicado: (2021)

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)
por: Kleineberg, Nina N., et al.
Publicado: (2021)

Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry
por: Cremer, Sebastian, et al.
Publicado: (2020)

Corrigendum to “Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases”[Artificial Intelligence in Life Sciences] 1(2021), 100020
por: Linden, Thomas, et al.
Publicado: (2022)

Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases
por: Linden, Thomas, et al.
Publicado: (2021)

Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany
por: Koppe, Uwe, et al.
Publicado: (2023)

Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
por: Schmidt-Hellerau, Kirsten, et al.
Publicado: (2023)

Age and Comorbidity Burden of Patients Critically Ill with COVID-19 Affect Both Access to and Outcome of Ventilation Therapy in Intensive Care Units
por: de Hesselle, Marie Louise, et al.
Publicado: (2023)

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients
por: Gliga, Smaranda, et al.
Publicado: (2022)

Quantitative analysis of different respiratory specimens on two automated test systems for detection of SARS-CoV-2 RNA
por: Lübke, Nadine, et al.
Publicado: (2023)

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
por: Jakob, Carolin E. M., et al.
Publicado: (2021)

Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
por: Orth, Hans Martin, et al.
Publicado: (2022)

Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany
por: Jensen, Bjoern, et al.
Publicado: (2021)

COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity
por: Heissig, Beate, et al.
Publicado: (2022)

Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
por: Bartenschlager, Christina C., et al.
Publicado: (2023)

Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure
por: Keitel, Verena, et al.
Publicado: (2021)

SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)
por: Pilgram, Lisa, et al.
Publicado: (2022)

Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease
por: Pilgram, Lisa, et al.
Publicado: (2021)

Invasiveness of Ventilation Therapy Is Associated to Prevalence of Secondary Bacterial and Fungal Infections in Critically Ill COVID-19 Patients
por: de Hesselle, Marie Louise, et al.
Publicado: (2022)

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
por: Popescu, Cristina, et al.
Publicado: (2011)

Disseminated Cryptococcosis Is a Common Finding among Human Immunodeficiency Virus-Infected Patients with Suspected Sepsis and Is Associated with Higher Mortality Rates
por: Tufa, Tafese Beyene, et al.
Publicado: (2023)

Response to Invited Commentary “Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population”
por: Hugo, Christian, et al.
Publicado: (2021)

Myelitis with flaccid paralysis due to Japanese encephalitis: case report and review of the literature
por: Grewe, Steven, et al.
Publicado: (2022)

Risk-adjusted active tuberculosis case finding strategy in central Ethiopia
por: Fuchs, Andre, et al.
Publicado: (2022)

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
por: Cremer, Sebastian, et al.
Publicado: (2021)

Gallbladder Wall Thickening associated with Dengue Shock Syndrome in a German traveller – no indication for surgical therapy – a case report
por: Freise, Noemi F., et al.
Publicado: (2021)

Dokumentation und Information: auf dem Weg ins Informationszeitalter
por: Lutterbeck, Ernst
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_gj1l842fpic71g4ad6hfqcelpc